These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16918372)

  • 41. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.
    Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients.
    Lee CT; Chua S; Hsu CY; Tsai YC; Ng HY; Kuo CC; Wu CH; Chen TC; Chiu TT; Lee YT
    Dis Markers; 2013; 34(4):229-35. PubMed ID: 23396289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins.
    Moe SM; O'Neill KD; Duan D; Ahmed S; Chen NX; Leapman SB; Fineberg N; Kopecky K
    Kidney Int; 2002 Feb; 61(2):638-47. PubMed ID: 11849407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of bone-regulatory proteins in human valve allografts.
    Shetty R; Pepin A; Charest A; Perron J; Doyle D; Voisine P; Dagenais F; Pibarot P; Mathieu P
    Heart; 2006 Sep; 92(9):1303-8. PubMed ID: 16449517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular calcification mechanisms.
    Giachelli CM
    J Am Soc Nephrol; 2004 Dec; 15(12):2959-64. PubMed ID: 15579497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
    Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
    Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-18 Enhances Vascular Calcification and Osteogenic Differentiation of Vascular Smooth Muscle Cells Through TRPM7 Activation.
    Zhang K; Zhang Y; Feng W; Chen R; Chen J; Touyz RM; Wang J; Huang H
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1933-1943. PubMed ID: 28860220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender-Related Differences in Chronic Kidney Disease-Associated Vascular Calcification Risk and Potential Risk Mediators: A Scoping Review.
    Wu PY; Lee SY; Chang KV; Chao CT; Huang JW
    Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulatory mechanisms in vascular calcification.
    Sage AP; Tintut Y; Demer LL
    Nat Rev Cardiol; 2010 Sep; 7(9):528-36. PubMed ID: 20664518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis.
    Engelse MA; Neele JM; Bronckers AL; Pannekoek H; de Vries CJ
    Cardiovasc Res; 2001 Nov; 52(2):281-9. PubMed ID: 11684076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).
    Moe SM; Reslerova M; Ketteler M; O'neill K; Duan D; Koczman J; Westenfeld R; Jahnen-Dechent W; Chen NX
    Kidney Int; 2005 Jun; 67(6):2295-304. PubMed ID: 15882271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.
    Toussaint ND; Kerr PG
    Nephrology (Carlton); 2007 Oct; 12(5):500-9. PubMed ID: 17803475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular calcification in chronic kidney disease.
    Covic A; Kanbay M; Voroneanu L; Turgut F; Serban DN; Serban IL; Goldsmith DJ
    Clin Sci (Lond); 2010 Apr; 119(3):111-21. PubMed ID: 20443781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF
    Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulatory circuits controlling vascular cell calcification.
    Sallam T; Cheng H; Demer LL; Tintut Y
    Cell Mol Life Sci; 2013 Sep; 70(17):3187-97. PubMed ID: 23269436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of vascular calcification in chronic kidney disease.
    Moe SM; Chen NX
    Circ Res; 2004 Sep; 95(6):560-7. PubMed ID: 15375022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis].
    Nitta K
    Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulatory mechanisms in vascular calcification.
    Boström K; Demer LL
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):151-8. PubMed ID: 11186330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
    D'Amelio P; Isaia G; Isaia GC
    J Endocrinol Invest; 2009; 32(4 Suppl):6-9. PubMed ID: 19724159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular calcification: mechanisms and clinical ramifications.
    Abedin M; Tintut Y; Demer LL
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1161-70. PubMed ID: 15155384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.